Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hearing Loss × Drug Therapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 21 Colorectal Neoplasms 10 Neoplasms 9 Stomach Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 7 Neoplasm Metastasis 5 Colonic Neoplasms 5 Esophageal Squamous Cell Carcinoma 4 Esophageal Neoplasms 4 Triple Negative Breast Neoplasms 3 Small Cell Lung Carcinoma 3 Pancreatic Neoplasms 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Acute 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Osteosarcoma 2 Neoplasms, Second Primary 2 Multiple Myeloma 2 Melanoma 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Head and Neck Neoplasms 2 Fatigue 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Thyroid Diseases 1

Interventions

Radiotherapy 1 Radiosurgery 1 Drug Therapy 1 Chemoradiotherapy 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06551857 2025-04-16

CaSPiN

Turku University Hospital

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡